LIN28B and hepatocellular carcinoma: LIN28B is involved in an epigenetic switch that links inflammation to cell transformation [5], HBx-induced hepatocarcinogenesis [18–21], HCC development and progression [10, 18, 22, 23] and the prognosis of HCC patients [22].